Navigation Links
Phase III Trial Begins for GAMMAGARD LIQUID Plus rHuPH20 in Primary Immunodeficiency Patients
Date:1/5/2009

akob disease (CJD) agent.

Components used in the packaging of this product are latex-free.

Thrombotic events have been reported in association with IGIV. Patients at risk may include those with a history of atherosclerosis, multiple cardiovascular risk factors, advanced age, impaired cardiac output, and/or known or suspected hyperviscosity, hypercoagulable disorders, and prolonged periods of immobilization.

IGIV products can contain blood group antibodies that may cause a positive direct antiglobulin reaction and, rarely, hemolysis.

Aseptic meningitis syndrome (AMS) has been reported to occur infrequently in association with IGIV treatment. Discontinuation of IGIV treatment has resulted in remission of AMS within several days without sequelae.

Various mild and moderate reactions, such as headache, fever, fatigue, chills, flushing, dizziness, urticaria, wheezing or chest tightness, nausea, vomiting, rigors, back pain, chest pain, muscle cramps, and changes in blood pressure may occur with infusions of Immune Globulin Intravenous (Human).

For full prescribing information, please visit: http://www.baxter.com/products/biopharmaceuticals/downloads/gamliquid_PI.pdf

About Baxter

Baxter International Inc. develops, manufactures and markets products that save and sustain the lives of people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma, and other chronic and acute medical conditions. As a global, diversified healthcare company, Baxter applies a unique combination of expertise in medical devices, pharmaceuticals and biotechnology to create products that advance patient care worldwide.

About Halozyme Therapeutics, Inc.

Halozyme is a biopharmaceutical company developing and commerciali
'/>"/>

SOURCE Halozyme Therapeutics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. YM BIOSCIENCES NIMOTUZUMAB SELECTED FOR MULTINATIONAL PHASE III TRIAL BY NATIONAL CANCER CENTRE OF SINGAPORE
2. Anesiva Phase 3 Trial of Adlea Meets Primary Endpoint to Significantly Reduce Pain After Total Knee Replacement Surgery
3. Cylene Pharmaceuticals Initiates Phase II Clinical Trial of Quarfloxin (CX-3543) in Patients With Carcinoid/Neuroendocrine Tumors
4. Enrollment in Delcaths Pivotal Phase III Metastatic Melanoma Clinical Trial Reaches Halfway Point
5. Oncolytics Biotech Inc.s REOLYSIN(R) Exceeds Primary Statistical Endpoint in U.S. Phase 2 Sarcoma Study
6. The American Ceramic Society releases new ACerS-NIST phase equilibria diagrams CD-ROM database
7. Phase 3 Data Demonstrate Efficacy and Tolerability of Paliperidone Palmitate, an Investigational Long-Acting Therapy for the Treatment of Schizophrenia
8. Nuvelo Announces Positive Results from Phase 1 Clinical Trial of NU206 in Healthy Volunteers
9. Proteolix Announces Positive Data From Two Ongoing Phase 2 Clinical Trials of Carfilzomib in Multiple Myeloma at the 50th Annual Meeting of the American Society of Hematology
10. Nile Therapeutics Announces Positive Results from Phase 1b Safety and Pharmacodynamics Study of CD-NP in Patients with Heart Failure
11. Omeros Announces Results from a Phase 1 Study of OMS201 for Use During Urological Surgery
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2014)... -- DeepResearchReports.com adds "2014 Market Research Report on ... Report on Global Ammonium Acetate Industry" reports to ... http://photos.prnewswire.com/prnh/20140902/141873 2014 Market Research ... professional and in-depth research report on ... The report introduces Sodium Bicarbonate basic information, definition, ...
(Date:9/2/2014)... The Little Company of Mary Hospital in Evergreen ... square-foot West Pavilion patient tower, which included the selection ... for the nurse’s lounge near the maternity ward. ... Hospital’s $180 million, four-year Campus Transformation project is ... the West Pavilion tower to the North Pavilion, as ...
(Date:9/2/2014)... and BELLINGHAM, Washington, USA (PRWEB) September 02, 2014 ... International Year of Light and Light-based Technologies (IYL 2015) ... top awards from SPIE, the international society for ... Awards were presented to Levinson and Dudley along with ... Medal of the Society won by James Harrington, during ...
(Date:9/2/2014)... HILL and NEW PROVIDENCE, N.J. ... America, Inc. is a corporate sponsor for MassBio,s ... its sister organization, the MassBioEd Foundation. The event will ... Golf Club in Plymouth, Massachusetts . ... biotechnology education in Massachusetts through ...
Breaking Biology Technology:Sodium Bicarbonate Market & Ammonium Acetate Industry: China & Global Analysis 2Sodium Bicarbonate Market & Ammonium Acetate Industry: China & Global Analysis 3Sodium Bicarbonate Market & Ammonium Acetate Industry: China & Global Analysis 4Sodium Bicarbonate Market & Ammonium Acetate Industry: China & Global Analysis 5Tufftec® Lockers from Scranton Products Selected by Little Company of Mary Hospital Near Chicago to Create an Uplifting Environment 2Tufftec® Lockers from Scranton Products Selected by Little Company of Mary Hospital Near Chicago to Create an Uplifting Environment 3Levinson, Dudley Win SPIE Directors’ and President’s Awards 2Levinson, Dudley Win SPIE Directors’ and President’s Awards 3Levinson, Dudley Win SPIE Directors’ and President’s Awards 4Linde helps fund STEM education in Massachusetts 2Linde helps fund STEM education in Massachusetts 3
... Vista Partners announced,today that it has updated ... ABMC ) and maintains its twelve month target ... Vista Partners stated, "Sales,internationally continue to increase and ... exposure in numerous testing centers, continue,to increase as ...
... Enrich Current Coverage With Regional Perspective, PHILADELPHIA ... leading provider of information solutions to the worldwide,research ... social,science journals have been added to Web of ... target a regional rather than,international audience by approaching ...
... March 31, 2008 Human,Pheromone Sciences, Inc. (OTC Bulletin ... the three months and the year ended,December 31, 2007. ... was $389,000, representing a 6% decrease from revenues of ... income of $38,000 ($.01 per,share) as compared with a ...
Cached Biology Technology:Vista Partners Updates Coverage; Maintains $3.20 Target Price 2Thomson Scientific Begins Expansion of Web of Science 2Human Pheromone Sciences Announces Quarterly and Full Year Results 2Human Pheromone Sciences Announces Quarterly and Full Year Results 3Human Pheromone Sciences Announces Quarterly and Full Year Results 4
(Date:9/2/2014)... a U.S. suburb , Observations and mapping by ... hours and days after the August 24 earthquake in ... caused so much damage in the region, according to ... the American Geophysical Union. , From ... to Direct Our Curiosity , Selecting where the ...
(Date:9/2/2014)... 3, The Field Museum will present the prestigious Parker/Gentry ... his commitment to biodiversity conservation awareness. The Parker/Gentry Award ... outstanding individual, team or organization whose efforts have had ... heritage and whose actions can serve as a model ... Mongabay.com, an environmental science and conservation news website that ...
(Date:9/2/2014)... Tithonian Konservat-Lagersttte of lithographic limestone is well known ... fossils from that area (for example, Archaeopteryx). Now, ... insects in the French equivalent of these outcrops ... the oldest known water treader. , Despite the ... fewer fossils have been obtained from the Late ...
Breaking Biology News(10 mins):This week From AGU: California earthquake, future Mars rovers, models underestimate ozone 2Exceptionally well preserved insect fossils from the Rhône Valley 2
... the first study evaluating the use of human urine mixed ... found that the combination can be substituted for costly synthetic ... risk of disease for consumers. The study appears in the ... Chemistry , a bi-weekly publication. In the study, ...
... the energy consumption of cells have a different structure and ... people, according to a new study from the Swedish medical ... researchers believe that these ,epigenetic mutations, might have a key ... Type II diabetes is characterised by a lower sensitivity ...
... This release is available in German . ... know-how in micro- and nanotechnologies for users from science ... KIT is starting operation: Ten leading institutions from research ... a total of 36 high-tech installations along with the ...
Cached Biology News:Scientific pathways into the nanoworld 2Scientific pathways into the nanoworld 3
Normal human serum collected off the clot from healthy normal humans. Each donor unit is negative for anti-HIV 1&2, HIV-Ag, HCV, and HBsAg by FDA required tests...
One-step, colorimetric, linear detection range 0.7 mg/dL to 300 mg/dL. Procedure: 10 min....
XBP1 Antibody...
... Designed to histochemically ... in distinct pH in ... sections. The specific marker ... senescent cells (not found ...
Biology Products: